On January 26, heart and valve disease experts, Dr. Vasilis Babaliaros and Dr. Adam Greenbaum of Emory Structural Heart & Valve Center, join us in studio to discuss heart valve disease.
Vasilis Babaliaros, M.D.
Vasilis Babaliaros, MD is the co-director of the Emory Structural Heart & Valve Center at Emory Healthcare and co-director of the Adult Congenital Heart Intervention team within the Emory Adult Congenital Heart Center. He has more than 10 years experience in interventional cardiology focused on structural heart and valve disease including clinical research.
Dr. Babaliaros is a Professor of Medicine of Interventional Cardiology at Emory University. He received his Biomedical Engineering degree at Duke University (1992), his medical degree at Emory University (1996), and completed his training in Internal Medicine and Cardiology at Emory (2003). In 2004, he completed fellowship training in Interventional Cardiology at Emory University and then continued sub-specialty training in Valvular Interventional Cardiology under Alain Cribier, MD at the University of Rouen, France (2005). He joined the faculty working with Peter Block, MD as the Associate Director of the Emory Center for Valvular Intervention and Structural Heart Disease Treatment in 2006. Dr. Babaliarosí research interests are in Valvular and Structural Heart Disease. Specifically, he was a member of the original team that pioneered percutaneous aortic valve replacement in France. His research efforts continue in the field of aortic stenosis, but have also grown to include catheter-based therapies for the treatment of mitral regurgitation, aortic insufficiency, and pulmonic valve disease. He is also involved in the current circulatory assist devices that are placed percutaneously for the treatment of cardiogenic shock and high-risk intervention support. Dr. Babaliaros teaches general cardiology and heart catheterization, but devotes most of his teaching efforts training future interventional cardiologists catheter techniques for the treatment of valvular heart disease and circulatory support. He also teaches medical students, medical residents and cardiology fellows clinical research.
Adam Greenbaum, M.D.
Adam Greenbaum, MD, has joined Emory School of Medicine as an Associate Professor of Medicine and Co-director of the Emory Structural Heart and Valve Center.
Dr. Greenbaum has dedicated his career to advancing medicine through clinical research, putting his leading-edge ideas into practice through patient care and teaching future generations of doctors through resident and fellow education. He has received numerous patient care and teaching awards and is recognized as a clinical expert in the field of structural heart disease. He’s also authored numerous research articles in the specialty of cardiovascular disease, especially structural heart disease.
Patients with structural heart problems have new treatment options because of the truly novel minimally invasive techniques Dr. Greenbaum developed. And his transcatheter methods and approaches to valvular heart disease bring new hope to patients with no other options.
Before joining Emory, he served at Henry Ford Heart and Vascular Institute in Detroit, Michigan for the past 19 years. He held positions as Co-director of the Center for Structural Heart Disease, Director of the Cardiac Catheterization Laboratory and Director of the Interventional Fellowship Program.
He is board-certified in general and interventional cardiology and is a Fellow of the American College of Cardiology, the American Heart Association and the Society for Cardiovascular Angiography and Interventions.
Dr. Greenbaum graduated from the New York University School of Medicine in New York, NY. He completed his internal medicine training at the University of Michigan in Ann Arbor, MI and his general and interventional cardiology training at Duke University in Durham, NC.